Open access · CC-BY
via OpenAlex
Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses
Anil B. Mukherjee, Abhilash Puthuvelvippel Appu, Tamal Sadhukhan, Sydney Casey, Avisek Mondal, Zhongjian Zhang, Maria Bindu Bagh
Molecular Neurodegeneration · 2019 · ▲ 104 citations
Abstract
Neuronal Ceroid Lipofuscinoses (NCLs), commonly known as Batten disease, constitute a group of the most prevalent neurodegenerative lysosomal storage disorders (LSDs). Mutations in at least 13 different genes (called CLNs) cause various forms of NCLs. Clinically, the NCLs manifest early impairment of vision, progressive decline in cognitive and motor functions, seizures and a shortened lifespan. At the cellular level, all NCLs show intracellular accumulation of autofluorescent material (called ceroid) and progressive neuron loss. Despite intense studies the normal physiological functions of each of the CLN genes remain poorly understood. Consequently, the development of mechanism-based therapeutic strategies remains challenging. Endolysosomal dysfunction contributes to pathogenesis of virtually all LSDs. Studies within the past decade have drastically changed the notion that the lysosomes are merely the terminal degradative organelles. The emerging new roles of the lysosome include its central role in nutrient-dependent signal transduction regulating metabolism and cellular proliferation or quiescence. In this review, we first provide a brief overview of the endolysosomal and autophagic pathways, lysosomal acidification and endosome-lysosome and autophagosome-lysosome fusions. We emphasize the importance of these processes as their dysregulation leads to pathogenesis of many LSDs including the NCLs. We also describe what is currently known about each of the 13 CLN genes and their products and how understanding the emerging new roles of the lysosome may clarify the underlying pathogenic mechanisms of the NCLs. Finally, we discuss the current and emerging therapeutic strategies for various NCLs.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s13024-018-0300-6
- Canonical
- link ↗
- Fetched
- 2026-10-02 MST
Cite this
APA
Mukherjee, A.B., Appu, A.P., Sadhukhan, T., Casey, S., Mondal, A., Zhang, Z., & Bagh, M.B. (2019). Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses. <em>Molecular Neurodegeneration</em>. https://doi.org/10.1186/s13024-018-0300-6
Vancouver
Mukherjee AB, Appu AP, Sadhukhan T, Casey S, Mondal A, Zhang Z, et al. Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses. Molecular Neurodegeneration. 2019. doi:10.1186/s13024-018-0300-6.
BibTeX
@article{anil2019Emergi,
title = {Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses},
author = {Anil B. Mukherjee and Abhilash Puthuvelvippel Appu and Tamal Sadhukhan and Sydney Casey and Avisek Mondal and Zhongjian Zhang and Maria Bindu Bagh},
journal = {Molecular Neurodegeneration},
year = {2019},
doi = {10.1186/s13024-018-0300-6},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Molecular neurodegeneration 2026
Open access · OA
Advancing a systems-level understanding of neurodegeneration: the BrightFocus Alzheimer's disease research portfolio.
Translational Neurodegeneration 2020
Open access · CC-BY
The emerging roles of vacuolar-type ATPase-dependent Lysosomal acidification in neurodegenerative diseases
Molecular neurobiology 2026
Open access · OA
Aryl Hydrocarbon Receptor Signaling in Aging: A Key Modulator of Brain Homeostasis.
International Journal of Pharmacy and Pharmaceutical Sciences 2026
Open access · CC-BY
SIRTUINS: POTENTIAL PHARMACOLOGICAL TARGET IN VARIOUS DISORDERS
Molecules 2024
Open access · CC-BY
Current Trends in Sirtuin Activator and Inhibitor Development
Cells 2026
Open access · OA